Commitments and Contingencies - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Product Liability Contingency [Line Items]
Accounts payable and accrued liabilities			$ 100,000
Accounts Payable and Accrued Expense Related Party			67,050
Drug Product Testing Agreement Consideration To Be Paid In Stages	190,000	370,000
Operating Leases, Future Minimum Payments Due	362,000
Other Inventory, Gross	$ 358,897		$ 154,667